Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions View by Topic View by Date Must Reads In Rheumatology Rheumatology for January/February 2021 Osteoporosis prevalence in PsA similar to general population, More must reads Rheumatology for November/December 2020 Weight loss may be paramount lifestyle change in preventing gout, Gut microbiome influences response to methotrexate in new-onset RA patients, Oral steroids plus PPIs increase osteoporotic fracture risk in RA patients, Etanercept may not help some with suspected nonradiographic axial spondyloarthritis, High-need, high-cost lupus patients described for first time, More must readsRheumatology for September/October 2020 Novel study explores link between primary immunodeficiencies, rheumatic diseases, Lower TNF inhibitor efficacy observed in women with nonradiographic axSpA, Guselkumab improvements for psoriatic arthritis persist through 1 year, Decline in febuxostat use trends with cardiovascular concerns, Shingrix effective in older adults with preexisting immune-mediated disorders, More must readsRheumatology for July/August 2020 SGLT2 inhibitors with metformin look safe for bone, The evidence is not clear: Rheumatic diseases, drugs, and COVID-19, RA patients show decreased risk for new-onset type 2 diabetes, Biologics may delay psoriatic arthritis, study finds, Bisphosphonates may have limited ‘protective’ effect against knee OA progression, More must readsRheumatology for May/June 2020 DECT has mixed performance in differentiating gout vs. CPPD, Belimumab safely improved renal function in lupus nephritis patients, Studies give new insight on starting, stopping etanercept in nonradiographic axSpA, Seropositivity in RA linked with doubled pneumonia incidence, Entheseal lesions, bone density linked with incident PsA in psoriasis patients, More must readsPages1 2 3 4 5 last »
